Sign In
Buy SIBN
$17.76
-0.230 (-1.28%)
At Close: Jul 31, 2026
SI-BONE To Report Second Quarter 2026 Financial Results on August 3, 2026
04:09pm, Monday, 20'th Jul 2026
SANTA CLARA, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bon
ViCentra Appoints Ian Wells as Chief Financial Officer and Adds Medtech Veteran Tom West to its Board
03:30am, Tuesday, 14'th Jul 2026
Ian Wells, former Global Chief Financial Officer of HOYA Vision Care, appointed CFO, bringing multi-billion-dollar P&L leadership and capital-markets discipline Tom West, who led Intersect ENT to its
SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026
04:09pm, Thursday, 04'th Jun 2026
SANTA CLARA, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bon
Bears are Losing Control Over Si-Bone (SIBN), Here's Why It's a 'Buy' Now
10:56am, Wednesday, 03'rd Jun 2026
Si-Bone (SIBN) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a tre
Wall Street Analysts Predict a 71.13% Upside in Si-Bone (SIBN): Here's What You Should Know
10:56am, Monday, 01'st Jun 2026
The average of price targets set by Wall Street analysts indicates a potential upside of 71.1% in Si-Bone (SIBN). While the effectiveness of this highly sought-after metric is questionable, the positi
Gazprom Neft says Q1 profit down 3.5% y/y
10:17am, Friday, 29'th May 2026
Gazprom Neft , the oil arm of Russia's energy giant Gazprom , said on Friday its first-quarter net profit declined by 3.5% year-on-year to 95.8 billion roubles ($1.35 billio
How Much Upside is Left in Si-Bone (SIBN)? Wall Street Analysts Think 65.27%
10:55am, Friday, 15'th May 2026
The consensus price target hints at a 65.3% upside potential for Si-Bone (SIBN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate
SI-BONE, Inc. (SIBN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
02:50pm, Tuesday, 12'th May 2026
SI-BONE, Inc. (SIBN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
SI-BONE, Inc. (SIBN) Q1 2026 Earnings Call Transcript
09:50am, Tuesday, 12'th May 2026
SI-BONE, Inc. (SIBN) Q1 2026 Earnings Call Transcript
SiBone Q1 Earnings Call Highlights
10:15pm, Monday, 11'th May 2026
SiBone NASDAQ: SIBN raised its full-year 2026 outlook after reporting double-digit revenue growth in the first quarter, with management pointing to new product launches, expanding physician adoption,
Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates
09:06pm, Monday, 11'th May 2026
Si-Bone (SIBN) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.15 per share a year ago.
SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance
04:09pm, Monday, 11'th May 2026
Delivered ~11% worldwide revenue growth, record physician engagement and ~440% improvement in adjusted EBITDA Delivered ~11% worldwide revenue growth, record physician engagement and ~440% improvement
First Eagle Small Cap Opportunity Fund Q1 2026 Portfolio Review
01:23pm, Wednesday, 06'th May 2026
Leading contributors in the First Eagle Small Cap Opportunity Fund this quarter included Ultra Clean Holdings, Oil States International, Lincoln Educational Services, Advanced Energy and FormFactor. O
SI-BONE To Present at BofA Securities 2026 Healthcare Conference on May 12, 2026
04:09pm, Thursday, 30'th Apr 2026
SANTA CLARA, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bo
SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026
04:09pm, Monday, 20'th Apr 2026
SANTA CLARA, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bo
